GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (OTCPK:NONOF) » Definitions » Price-to-Tangible-Book

Novo Nordisk A/S (Novo Nordisk A/S) Price-to-Tangible-Book : 82.27 (As of Apr. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Novo Nordisk A/S Price-to-Tangible-Book?

As of today (2024-04-26), Novo Nordisk A/S's share price is $124.64. Novo Nordisk A/S's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $1.52. Hence, Novo Nordisk A/S's Price to Tangible Book Ratio of today is 82.27.

The historical rank and industry rank for Novo Nordisk A/S's Price-to-Tangible-Book or its related term are showing as below:

NONOF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 15.26   Med: 20.6   Max: 87.59
Current: 84.79

During the past 13 years, Novo Nordisk A/S's highest Price to Tangible Book Ratio was 87.59. The lowest was 15.26. And the median was 20.60.

NONOF's Price-to-Tangible-Book is ranked worse than
99.1% of 1220 companies
in the Biotechnology industry
Industry Median: 2.68 vs NONOF: 84.79

A closely related ratio is called PB Ratio. As of today, Novo Nordisk A/S's share price is $124.64. Novo Nordisk A/S's Book Value per Sharefor the quarter that ended in Dec. 2023 was $3.50. Hence, Novo Nordisk A/S's P/B Ratio of today is 35.64.


Novo Nordisk A/S Price-to-Tangible-Book Historical Data

The historical data trend for Novo Nordisk A/S's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Price-to-Tangible-Book Chart

Novo Nordisk A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.03 24.16 61.21 66.27 67.66

Novo Nordisk A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.27 83.72 62.69 76.34 67.66

Competitive Comparison of Novo Nordisk A/S's Price-to-Tangible-Book

For the Biotechnology subindustry, Novo Nordisk A/S's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Nordisk A/S's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novo Nordisk A/S's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Novo Nordisk A/S's Price-to-Tangible-Book falls into.



Novo Nordisk A/S Price-to-Tangible-Book Calculation

Novo Nordisk A/S's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=124.64/1.515
=82.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Novo Nordisk A/S Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Nordisk A/S (Novo Nordisk A/S) Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, DK-2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S (Novo Nordisk A/S) Headlines